Invest in

Biotech Breakthroughs

3.5%
1.7%
0.0%

Feeling Better About Biotech

The next big cure for a complex, scary disease is unlikely to come from old-school pharma. It’s likely coming from biotech. Scientists, investors, and patients are all banking on the $93 billion biotech industry.[1] It’s outpaced Big Pharma in finding treatments for cancer, AIDS, multiple sclerosis, and other diseases. The FDA approved 43 drugs in 2012, a 20% jump from the previous year.[4] Big Pharma has responded by snapping up promising biotech and smaller pharmaceutical companies, at lofty valuations, with premiums for several public companies in excess of 50%.[2] In fact, 2013 was a big year for the biotech industry, with $29B in M&A deals through the 1st half of 2013.[3] This motif includes only biotech companies with at least two years of cash flow to help screen out companies at greater risk of losing money. See more
3.5%
1.7%
0.0%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Biotech Breakthroughs Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
35.0% Cancer 11.5%
19.9% Amgen Inc. AMGN 23.5%
13.0% Celgene Corporation CELG 5.5%
1.2% Seattle Genetics Inc. SGEN 28.0%
0.9% Spectrum Pharmaceuticals Inc. SPPI 31.1%
18.8% Autoimmune Disorders 2.2%
10.2% Biogen Inc. BIIB 5.5%
3.3% Incyte Corporation INCY 23.4%
3.0% BioMarin Pharmaceutical Inc. BMRN 17.3%
1.2% Galapagos NV Spons ADR GLPG 10.8%
1.0% Rigel Pharmaceuticals Inc. RIGL 17.0%
16.5% Other Diseases 18.2%
5.7% Regeneron Pharmaceuticals Inc. REGN 24.0%
4.4% Alexion Pharmaceuticals Inc. ALXN 16.3%
3.6% Vertex Pharmaceuticals Incorporated VRTX 17.7%
1.8% United Therapeutics Corporation UTHR 10.5%
1.0% Repligen Corporation RGEN 9.5%
16.0% Infectious Diseases 20.3%
15.0% Gilead Sciences Inc. GILD 21.1%
1.0% Emergent Biosolutions Inc. EBS 7.8%
13.8% Research & Diagnostics 0.9%
4.9% Quintiles Transnational Holdings Inc. Q 2.8%
4.3% Qiagen N.V. QGEN 0.3%
3.6% Illumina Inc. ILMN 5.6%
1.0% Meridian Bioscience Inc. VIVO 17.9%

Quotes delayed 15 mins. Currently Sep 26, 2016 6:25:40 AM. Fields are marked with -- when data is unavailable.